Manzo Financial Statements From 2010 to 2025

MNZO Stock  USD 0.0001  0.00  0.00%   
Manzo Pharmaceut's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Manzo Pharmaceut's valuation are provided below:
Gross Profit
-517.2 K
Market Capitalization
116 K
We have found one hundred seven available fundamental ratios for Manzo Pharmaceut, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Manzo Pharmaceut's last-minute fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 2nd of August 2025, Market Cap is likely to grow to about 1.6 M, while Enterprise Value is likely to drop about 734.5 K.

Manzo Pharmaceut Total Revenue

1,721.97

Check Manzo Pharmaceut financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Manzo Pharmaceut's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 2.6 M, as well as many indicators such as Price To Sales Ratio of 218, Ptb Ratio of 3.63 or Days Sales Outstanding of 0.0. Manzo financial statements analysis is a perfect complement when working with Manzo Pharmaceut Valuation or Volatility modules.
  
Build AI portfolio with Manzo Stock
Check out the analysis of Manzo Pharmaceut Correlation against competitors.
To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.

Manzo Pharmaceut Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets164.5 K173.2 K681 K
Slightly volatile
Other Current Liabilities12.4 K13.1 K368.8 K
Slightly volatile
Total Current Liabilities9.5 K10 K1.7 M
Slightly volatile
Accounts Payable428451687.9 K
Slightly volatile
Cash8.2 K11.1 K10.6 K
Slightly volatile
Net Receivables3.4 M3.6 M3.2 M
Slightly volatile
Other Current Assets111.9 K124.5 K136 K
Slightly volatile
Total Liabilities9.5 K10 K1.7 M
Slightly volatile
Short and Long Term Debt9.5 K10 K7.3 M
Slightly volatile
Total Current Assets10.5 K11.1 K304.1 K
Slightly volatile
Common Stock1.4 M1.3 M916.4 K
Slightly volatile
Property Plant Equipment1.8 MM1.3 M
Slightly volatile

Manzo Pharmaceut Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative2.6 M2.6 M2.9 M
Slightly volatile

Manzo Pharmaceut Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation601.5 K309.7 K396.5 K
Pretty Stable
Change To Operating Activities598.3 K817 K895.3 K
Slightly volatile
Total Cash From Financing Activities22.3 K23.5 K300.5 K
Slightly volatile
Change To Liabilities10 K10.5 K51 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio218311414
Slightly volatile
EV To Sales246300444
Slightly volatile
ROIC0.00450.00470.9783
Slightly volatile
Inventory Turnover1.251.41.5273
Slightly volatile
Days Of Inventory On Hand188211230
Slightly volatile
Payables Turnover5.096.787.1894
Very volatile
Cash Per Share0.00.02.0E-4
Slightly volatile
Days Payables Outstanding65.3355.751.3124
Very volatile
Income Quality0.360.310.284
Very volatile
Intangibles To Total Assets0.750.840.9184
Slightly volatile
Revenue Per Share0.00.00.0582
Slightly volatile
Interest Debt Per Share0.00.00.1579
Slightly volatile
Capex To Revenue0.0018.0E-48.0E-4
Very volatile
Capex Per Share9.0E-48.0E-47.0E-4
Very volatile
Operating Cycle188211230
Slightly volatile
Price Earnings To Growth Ratio0.150.170.188
Slightly volatile
Days Of Payables Outstanding65.3355.751.3124
Very volatile
Return On Capital Employed0.00330.00350.3794
Slightly volatile
Days Of Inventory Outstanding188211230
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.983
Slightly volatile
Fixed Asset Turnover2.012.422.6073
Slightly volatile
Price Sales Ratio218311414
Slightly volatile
Asset Turnover0.01140.0120.0578
Slightly volatile
Gross Profit Margin0.370.350.3806
Pretty Stable

Manzo Pharmaceut Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.6 M800.1 K823.4 K
Very volatile
Enterprise Value734.5 K773.2 K1.2 M
Slightly volatile

About Manzo Pharmaceut Financial Statements

Manzo Pharmaceut investors utilize fundamental indicators, such as revenue or net income, to predict how Manzo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue1.8 K1.7 K
Cost Of Revenue1.1 KK
Ebit Per Revenue 0.45  0.48 

Pair Trading with Manzo Pharmaceut

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Manzo Pharmaceut position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manzo Pharmaceut will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Manzo Pharmaceut could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Manzo Pharmaceut when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Manzo Pharmaceut - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Manzo Pharmaceut to buy it.
The correlation of Manzo Pharmaceut is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Manzo Pharmaceut moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Manzo Pharmaceut moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Manzo Pharmaceut can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Manzo Pharmaceut offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Manzo Pharmaceut's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Manzo Pharmaceut Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Manzo Pharmaceut Stock:
Check out the analysis of Manzo Pharmaceut Correlation against competitors.
To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.